drugset / Trial / NCT04258657

Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer

NCT04258657 ↗

Phase 2 Unknown 20 enrolled Beijing Friendship Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a interventional clinical trial to assess the efficacy and safety of combinational therapy of paclitaxel-albumin and S-1 for the neoadjuvant chemotherapy of advanced gastric cancer.

Timeline

Start
2020-03-01
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule — —
Subject S-1 Small molecule — —

Indications